Kidney Transplant Recipients Do Not Benefit From Infliximab

This study is the largest trial involving TNF blockade (via infliximab induction) in kidney transplant recipients.

Related Keywords

California , United States , West Hollywood , American , Peter Heeger , Center At Cedars Sinai Medical , Journal Of The American Society Nephrology , Comprehensive Transplant Center , Cedars Sinai Medical Center , American Society ,